Viewing Study NCT01934894


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:46 PM
Study NCT ID: NCT01934894
Status: TERMINATED
Last Update Posted: 2017-07-02
First Post: 2013-08-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
Sponsor: SCRI Development Innovations, LLC
Organization: